FDA Approves Unknown Drug — PHARMOBEDIENT
PHARMOBEDIENT received FDA approval for its ANDA on April 22, 2002, position the company to capture market share and increase competition within the relevant therapeutic segment.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day